DexCom had 23 patents in cybersecurity during Q1 2024. DexCom Inc’s patents filed in Q1 2024 focus on inter-app communications on mobile devices, processing and displaying data from analyte sensors, wireless communication of analyte data, and enhancing wireless communications between analyte sensor systems and other devices. The patents cover methods, devices, and systems for efficient data transmission, configuration, and communication in the field of diabetes management. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights DexCom Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

DexCom grant share with cybersecurity as a theme is 17% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Methods for providing an alert or an alarm to a user of a mobile communications device (Patent ID: US20240091442A1)

The patent filed by DexCom Inc. discloses methods, devices, and systems for inter-app communications on a mobile device, enabling data sharing between software applications within a shared app group. The communication data structure includes a scheme field with a scheme id for transitioning between apps and a payload field for encrypted data distribution. The patent also details a mobile communications device with multiple software applications for receiving glucose measurements, calculating insulin dosage, and transmitting commands to an insulin delivery device based on patient-specific input data.

The claims outline the functionality of the mobile communications device, including storing and retrieving data in a shared database, transmitting commands through different software applications, and encrypting information for secure access. The method involves executing different software applications to handle glucose measurements, insulin dosage calculations, and insulin delivery commands, with the ability to store, retrieve, and encrypt data for seamless communication between applications. The patent emphasizes the use of an inter-application communications architecture and a shared file system, such as a shared database, to facilitate efficient data exchange and processing on the mobile device.

To know more about GlobalData’s detailed insights on DexCom, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.